PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-04-26

Date Title Company
26-Apr-2024 Asia Green Biotechnology Corp. Announces Delay in Filing of Annual Financial Statements and Application for Management Cease Trade Order AccessWire
26-Apr-2024 RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting AccessWire
26-Apr-2024 RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting Relief Therapeutics Holding SA
26-Apr-2024 PharmaLink Inc. and Recall Results, Inc. Announce Strategic Partnership to Enhance Drug Safety and Recall Efficiency Newswire
26-Apr-2024 PharmaLink Inc. and Recall Results, Inc. Announce Strategic Partnership to Enhance Drug Safety and Recall Efficiency AccessWire
26-Apr-2024 ARAMEX SCOOPS ACCOLADE AT DISTRIBUTING PHARMACEUTICALS AWARDS Aramex
26-Apr-2024 CompendiRx Unveils Innovative Approach to Long COVID: Empowering Patients Worldwide AccessWire
26-Apr-2024 Stockholm, Sweden – April 26 2024 – OncoZenge AB (publ), a leading pharmaceutical company developing BupiZenge™, an innovative, non-opioid treatment for oral pain, today announces the appointment of Anna Asplind as Phase 3 Program Manager. OncoZenge
26-Apr-2024 HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda HUTCHMED
26-Apr-2024 Quest Diagnostics Foundation and Green Bronx Machine Expand Collaboration to Bring Acclaimed Indoor Gardening Curriculum to More Communities and Raise Awareness for Impact of Nutrition Education on Health Equity AccessWire
26-Apr-2024 Swedencare launches NaturVet by Swedencare: Bringing America’s leading pet brand to Europe Swedencare
26-Apr-2024 Senzime Signs its First Group Purchasing Organization (GPO) Contract with Major US Hospital System as Sole Source Supplier AccessWire
26-Apr-2024 OncoZenge Releases Paper on BupiZenge™ Addressing Unmet Medical Needs OncoZenge
26-Apr-2024 Liebherr presents its innovative cooling solutions at Clinical Pharmacy Congress 2024 Liebherr
26-Apr-2024 eyeDNA Therapeutics to Present 2-year Follow-up Phase I/II Data on its Investigational Gene Therapy HORA-PDE6b for Retinitis Pigmentosa at the ARVO 2024 Annual Meeting eyeDNA Therapeutics
26-Apr-2024 Curiteva Announces David Schmidt as Chief Commercial Officer AccessWire
26-Apr-2024 Notice Of Annual General Meeting in PMD Device Solutions AB (PUBL) AccessWire
26-Apr-2024 Biotricity's Path Towards Breakeven Accelerated by Latest Diagnostic Product, Biotres Pro, Garnering Rapid Interest from Existing and New Customers AccessWire
26-Apr-2024 Innovation in generics: Increased efficiency through peptide API synthesis expertise Bachem
26-Apr-2024 MDPE Pipe Market Size to Reach USD 206.8 Million by 2033 – Rise with Steller CAGR 7.7% Wired Release